Beating cancer with Harm Reduction
4.2.2021 11:24:05 CET | news aktuell GmbH | Pressemelding
Almost one third of cancer cases in Europe are caused by smoking:
“Tobacco consumption continues to be the leading cause of preventable cancer, with 27% of all cancers attributed to tobacco use. By eliminating tobacco use, nine out every ten cases of lung cancer could be avoided.”[1]
It is therefore more important than ever to use all means at hand to minimize smoking rates. Tobacco harm reduction is rated as a very good opportunity to significantly reduce the number of smokers. That is why it has to be included in an impactful EU Beating Cancer plan:
“When it comes to smoking cessation, the EU Commission is once again concentrating on the 'quit or die' approach instead of creating a realistic addiction policy.", says Prof Heino Stöver from the German Institute for Addiction Research at the Frankfurt University of Applied Sciences. And further: “Great Britain, New Zealand and Canada are putting the e- Cigarette as a main tool in the fight against tobacco use and have been shown to be very successful.”[2]
Cancer potencies: 0.5% of the risk of smoking
In embracing harm reduction the UK shows a better and more effective strategy to decrease the number of smokers. With broad education on harm-reducing alternatives, British health policy has drastically reduced the smoking rate within a few years. In 2011, 20 percent of the British still smoked, in 2019 it was around 14 percent.[3]
In 2018, the government agency Public Health England (PHE) published a report with data on e-cigarettes. According to PHE, vapers have a 99.5 percent lower risk of cancer than smokers. Overall, PHE estimates that e-cigarettes are at least 95 percent less harmful than tobacco cigarettes.[4]
Dustin Dahlmann, Chairman of IEVA: “We welcome the EU Beating Cancer Plan. The strategy needs to consider all means available to reduce the burden of cancer related risks: It is of utmost importance that preventive measures are flanked by tobacco harm reduction. Otherwise, millions of smokers might miss the opportunity to tremendously reduce their risk of cancer.”
[1] EU Beating Cancer Plan, 2021. Link
[2] Prof Heino Stöver, Press release, February 03, 2021. Link
[3] Adult smoking habits in the UK: 2019. Link
[4] “Evidence review of e-cigarettes and heated tobacco products”, Public Health England 2018. Link
Kontakter
Independent European Vape Alliance (IEVA)
President: Dustin Dahlmann
Press coordinator: Philip Drögemüller
Phone: +32 (2) 791 7759
E-Mail: p.droegemueller@eurovape.eu
Web: www.eurovape.eu
Lenker
Om news aktuell GmbH
IEVA - Independent European Vape Alliance
The Independent European Vape Alliance (IEVA) is the only pan-European association aimed at uniting national associations, companies, manufacturers and wholesalers in the vaping industry and providing them with responsible representation at the European level.
IEVA’s founding principle is to contribute to harm reduction and public health. E-cigarettes have a significant positive impact and should be recognized as a harm reduction tool because vaping is not smoking.
Følg pressemeldinger fra news aktuell GmbH
Registrer deg med din e-postadresse under for å få de nyeste sakene fra news aktuell GmbH på e-post fortløpende. Du kan melde deg av når som helst.
Siste pressemeldinger fra news aktuell GmbH
Grünenthal licenses exclusive South Korean rights to Qutenza® to BCWorld Pharm5.3.2026 08:54:06 CET | Press release
Aachen, Germany & Yeoju, South Korea, 5 March 2026 – Grünenthal, a global leader in pain management and related diseases, and BCWorld Pharm Co., Ltd. ("BCWP"), a specialty company actively expanding and diversifying its pain management portfolio through global open innovation partnerships, announced today that they have entered into a definitive agreement whereby BCWP will have the exclusive South Korean rights to Qutenza®, a topical, non-systemic, non-opioid patch treatment. In Europe, the product is indicated for the management of peripheral neuropathic pain.
Compax MVNE continues to support Airalo’s eSIM platform2.3.2026 14:46:10 CET | Press release
Compax, a leading solution provider in the MVNO and telco space, will continue to support Airalo, the world’s first and largest eSIM platform.
Grünenthal takes full ownership of Grünenthal Meds, the joint venture established with Kyowa Kirin for its established medicines brands2.3.2026 10:39:09 CET | Press release
Grünenthal acquired Kyowa Kirin International’s 49% stake in ‘Grünenthal Meds’, a joint venture formed in 2023 to market the established medicines portfolio from Kyowa Kirin International. Through this acquisition, Grünenthal assumes the sole responsibility of a portfolio comprising 12 brands across six therapeutic areas and >60 markets.
Valle Venia presents new song by LPS feat. Lara: Where will it take me27.2.2026 10:15:00 CET | Press release
The song describes the challenge of trusting the flow, relying on oneself, following one's own values with confidence.
Vyoma awarded ESA data procurement contract for space-based data on small space debris24.2.2026 10:53:34 CET | Press release
(Munich, February 24th, 2026) Vyoma, a Munich-based company providing Space Domain Awareness (SDA) capabilities, has been selected as the winner of the ESA tender on ”Data Procurement for Space-Based Statistical Data on Small Space Debris Phase 1”, funded via ESA‘s Space Safety Programme (S2P). ESA’s Meteoroid And Space debris Terrestrial Environment Reference (MASTER) model provides a description of the space environment around Earth, supporting satellite designers, operators and others with risk assessments. Currently, there exists a significant temporal and spatial knowledge gap for observations of space debris with sizes smaller than the detection limit of ground-based sensors. Vyoma's Flamingo-1 satellite is ideally positioned to generate the image data ESA is seeking. Flying “in-situ” at an altitude of 510 km, Flamingo-1's instrument can monitor large volumes of space at once. This sensor detects objects at long and short distances and captures small and fast objects reliably, im
I vårt presserom finner du alle våre siste pressemeldinger, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.
Besøk vårt presserom

